Determinants and patterns of antibiotic consumption for children under five in Nepal: analysis and modelling of Demographic Health Survey data from 2006 to 2016

listen audio

Study Justification:
The study aimed to examine the factors associated with antibiotic consumption in children under five in Nepal between 2006 and 2016. This is important because antibiotic resistance is a growing global health concern, and understanding the determinants and patterns of antibiotic use can help inform interventions to reduce inappropriate use while ensuring access for those who need them.
Highlights:
1. Prevalence of fever, acute respiratory infection (ARI), and diarrhea decreased between 2006 and 2016, while the proportion of children under five receiving antibiotics increased.
2. Factors associated with antibiotic use included measles vaccination, basic vaccinations, nutritional status, sanitation, and access to health care.
3. Antibiotic consumption in rural areas surpassed urban regions over time, and those in the highest wealth index used fewer antibiotics.
4. Health seeking from the private sector has overtaken government facilities since 2006, with antibiotics mainly originating from pharmacies and private hospitals.
5. Adherence to WHO-recommended antibiotics has fallen over time.
Recommendations:
1. Interventions should focus on reducing inappropriate antibiotic use while ensuring access to those who need them. This can be achieved through targeted education campaigns for healthcare providers and the general public.
2. Efforts should be made to improve vaccination coverage, nutritional status, and access to clean water and sanitation facilities, as these factors were associated with antibiotic use.
3. Strengthening government healthcare facilities and regulating the private sector can help ensure appropriate antibiotic use and reduce reliance on unregulated sources.
4. Monitoring and surveillance systems should be established to track antibiotic consumption and resistance patterns over time.
Key Role Players:
1. Ministry of Health: Responsible for implementing policies and interventions related to antibiotic use and resistance.
2. Healthcare providers: Play a crucial role in prescribing antibiotics appropriately and educating patients about their use.
3. Pharmaceutical industry: Should adhere to regulations and promote responsible antibiotic use.
4. Non-governmental organizations (NGOs): Can support awareness campaigns, education programs, and advocacy efforts.
5. Research institutions: Conduct further studies to monitor antibiotic consumption and resistance trends and evaluate the effectiveness of interventions.
Cost Items for Planning Recommendations:
1. Education campaigns: Budget for developing and disseminating educational materials, organizing workshops, and training healthcare providers.
2. Strengthening healthcare facilities: Allocate funds for infrastructure improvements, equipment, and staffing.
3. Monitoring and surveillance systems: Invest in data collection, analysis, and reporting tools.
4. Research studies: Allocate resources for conducting further research on antibiotic use and resistance.
5. Regulatory measures: Budget for implementing and enforcing regulations on antibiotic sales and use.
Please note that the cost items provided are general categories and should be further refined based on the specific context and requirements of the interventions.

The strength of evidence for this abstract is 8 out of 10.
The evidence in the abstract is strong because it is based on cross-sectional data from the 2006, 2011, and 2016 Demographic Health Surveys in Nepal. Bivariable and multivariable analyses were conducted to assess the association of disease prevalence and antibiotic use with various factors. The study also examined health care-seeking patterns and the source of antibiotics. The data collection methods and statistical analysis techniques used are appropriate. However, to improve the evidence, the abstract could provide more details on the sample size, response rate, and any limitations of the study. Additionally, including information on the statistical significance of the associations found would further strengthen the evidence.

Objectives: Our aims were to examine AMR-specific and AMR-sensitive factors associated with antibiotic consumption in Nepal between 2006 and 2016, to explore health care-seeking patterns and the source of antibiotics. Methods: Cross-sectional data from children under five in households in Nepal were extracted from the 2006, 2011 and 2016 Demographic Health Surveys (DHS). Bivariable and multivariable analyses were carried out to assess the association of disease prevalence and antibiotic use with age, sex, ecological location, urban/rural location, wealth index, household size, maternal smoking, use of clean fuel, sanitation, nutritional status, access to health care and vaccinations. Results: Prevalence of fever, acute respiratory infection (ARI) and diarrhoea decreased between 2006 and 2016, whilst the proportion of children under five receiving antibiotics increased. Measles vaccination, basic vaccinations, nutritional status, sanitation and access to health care were associated with antibiotic use. Those in the highest wealth index use less antibiotics and antibiotic consumption in rural areas surpassed urban regions over time. Health seeking from the private sector has overtaken government facilities since 2006 with antibiotics mainly originating from pharmacies and private hospitals. Adherence to WHO-recommended antibiotics has fallen over time. Conclusions: With rising wealth, there has been a decline in disease prevalence but an increase in antibiotic use and more access to unregulated sources. Understanding factors associated with antibiotic use will help to inform interventions to reduce inappropriate antibiotic use whilst ensuring access to those who need them.

Cross‐sectional data on living children under five in households in Nepal were extracted from the 2006, 2011 and 2016 DHS surveys through datasets and survey reports. The DHS survey collects data using a stratified 2‐stage cluster sampling method. The time frame for data collection was from February to August in 2006, February to June in 2011 and June to January in 2016. ARI was defined as fast breathing and/or difficulty breathing due to a problem in the chest with or without cough in the 2 weeks preceding the survey. This is concordant with the definition given by the WHO Integrated Management of Childhood Illnesses (IMCI) for pneumonia. Fever (parameters not specified in the survey) and diarrhoea (frequent loose or liquid stools) were defined as occurrence of the symptoms in the last 2 weeks. Dysentery was ascertained as the presence of diarrhoea with bloody stools. Occurrence of these symptoms was based on maternal/care‐giver recall. Care seeking was defined by whether the mother sought advice or treatment for the illness from any healthcare facility. Antibiotic treatment was assessed by asking the mother if the child had taken any drugs during the illness and if so, whether this consisted of antibiotic pills, syrups or injections. Rates of antibiotic use were calculated with the total under‐five population as the denominator to reflect antibiotic consumption at the population level. A full list of definitions can be found in Table S1. A descriptive analysis was carried out on the survey reports and datasets to identify changes from 2006 to 2016 with regard to demographics, disease prevalence and antibiotic use. A bivariable analysis was performed to evaluate both direct (AMR‐specific) risk factors (age, sex, wealth, location, maternal education, household size) and indirect (AMR‐sensitive) risk factors (maternal smoking, use of clean fuel, sanitation, water source, nutritional status, access to health care and vaccinations) for antibiotic use. Variables were chosen based on existing literature and expert opinion [10, 11]. Bivariable models were included to provide a comprehensive overview of all the risk factors being explored, including those that were not significant. The consistently significant factors in the bivariable analysis (age, wealth and location) were then included in the multivariable analysis using logistic regression. Factors not associated with the outcome in bivariable models were omitted from adjusted models to avoid data sparsity. Each survey year’s data set was modelled separately and results then compared across time periods. Sample weights provided by the DHS data were applied to account for over and undersampling of particular regions, and adjustments were made for clustering of data using Taylor‐linearised variance estimation. Health care‐seeking behaviours, the source of antibiotics and appropriate use in accordance with the WHO IMCI guidelines were also examined. Data management and analysis were carried out using Stata version SE 12. All data were publicly available and anonymised with ethical approval covered under the original data collection.

Based on the provided information, here are some potential innovations that could be recommended to improve access to maternal health:

1. Strengthening healthcare infrastructure: Investing in the development and improvement of healthcare facilities, particularly in rural areas, can enhance access to maternal health services. This includes ensuring the availability of skilled healthcare professionals, essential medical equipment, and necessary medications.

2. Promoting community-based healthcare: Implementing community-based healthcare programs can improve access to maternal health services, especially in remote areas. This involves training and empowering local healthcare workers to provide basic maternal healthcare services and education within their communities.

3. Mobile health (mHealth) interventions: Utilizing mobile technology to deliver maternal health information, reminders, and support can help overcome barriers to access. This can include sending SMS messages with important health tips, appointment reminders, and emergency contact information.

4. Telemedicine services: Implementing telemedicine services can enable pregnant women in remote areas to access healthcare professionals and receive medical advice through video consultations. This can help address the shortage of healthcare providers in underserved regions.

5. Maternal health awareness campaigns: Conducting targeted awareness campaigns to educate women and their families about the importance of maternal health, including antenatal care, skilled birth attendance, and postnatal care, can help increase utilization of maternal health services.

6. Financial incentives and subsidies: Providing financial incentives, such as cash transfers or subsidies, to pregnant women and their families can help alleviate the financial burden associated with accessing maternal health services. This can encourage more women to seek timely and appropriate care.

7. Strengthening referral systems: Improving the coordination and effectiveness of referral systems between different levels of healthcare facilities can ensure that pregnant women receive timely and appropriate care, especially in cases where specialized care is required.

8. Quality improvement initiatives: Implementing quality improvement initiatives in healthcare facilities can enhance the overall quality of maternal health services, leading to increased utilization and improved health outcomes for mothers and their newborns.

9. Integration of maternal health services: Integrating maternal health services with other healthcare programs, such as family planning and child health services, can improve access and continuity of care for women throughout the reproductive cycle.

10. Empowering women and promoting gender equality: Addressing social and cultural barriers that limit women’s access to maternal health services is crucial. Promoting gender equality, empowering women to make informed decisions about their health, and involving them in the design and implementation of maternal health programs can contribute to improved access and utilization of services.
AI Innovations Description
The recommendation that can be developed into an innovation to improve access to maternal health based on the provided information is to implement targeted interventions to reduce inappropriate antibiotic use while ensuring access to those who need them.

Specifically, the innovation could involve:

1. Education and awareness campaigns: Develop educational materials and campaigns targeting healthcare providers, mothers, and caregivers to raise awareness about appropriate antibiotic use and the risks of antibiotic resistance. This can help promote responsible antibiotic prescribing and discourage unnecessary antibiotic use.

2. Strengthening healthcare systems: Improve access to quality healthcare facilities, especially in rural areas, to ensure that mothers and children have access to appropriate healthcare services. This can involve increasing the number of healthcare facilities, training healthcare providers, and improving the availability of essential medicines, including antibiotics.

3. Regulation and monitoring of antibiotic sales: Implement regulations and monitoring systems to ensure that antibiotics are only sold with a prescription and dispensed by qualified healthcare professionals. This can help reduce the availability of antibiotics from unregulated sources, such as pharmacies and private hospitals, and promote appropriate antibiotic use.

4. Integration of maternal health services: Integrate maternal health services with existing healthcare systems to ensure comprehensive and coordinated care for mothers and children. This can involve integrating antenatal care, postnatal care, family planning services, and immunization programs to improve access to essential maternal health services.

5. Collaboration and partnerships: Foster collaboration and partnerships between government agencies, healthcare providers, non-governmental organizations, and community organizations to implement and sustain the recommended interventions. This can help leverage resources, expertise, and knowledge to effectively improve access to maternal health.

By implementing these recommendations, it is possible to develop an innovation that addresses the determinants and patterns of antibiotic consumption for children under five in Nepal and ultimately improves access to maternal health.
AI Innovations Methodology
The study titled “Determinants and patterns of antibiotic consumption for children under five in Nepal: analysis and modelling of Demographic Health Survey data from 2006 to 2016” aims to examine factors associated with antibiotic consumption in Nepal and explore health care-seeking patterns and the source of antibiotics. The methodology used in the study involves the analysis of cross-sectional data from children under five in households in Nepal, extracted from the 2006, 2011, and 2016 Demographic Health Surveys (DHS).

The data collection for the study was conducted using a stratified 2-stage cluster sampling method. The surveys were carried out from February to August in 2006, February to June in 2011, and June to January in 2016. The study focused on analyzing the prevalence of fever, acute respiratory infection (ARI), and diarrhea among children under five, as well as the proportion of children receiving antibiotics. The association of disease prevalence and antibiotic use with various factors such as age, sex, ecological location, urban/rural location, wealth index, household size, maternal smoking, use of clean fuel, sanitation, nutritional status, access to health care, and vaccinations was assessed through bivariable and multivariable analyses.

Descriptive analysis was performed to identify changes in demographics, disease prevalence, and antibiotic use from 2006 to 2016. Bivariable analysis evaluated both direct (AMR-specific) risk factors and indirect (AMR-sensitive) risk factors for antibiotic use. Logistic regression was used for the multivariable analysis, including factors that were consistently significant in the bivariable analysis. Each survey year’s dataset was modeled separately, and the results were compared across time periods.

The study also examined health care-seeking behaviors, the source of antibiotics, and adherence to WHO Integrated Management of Childhood Illnesses (IMCI) guidelines. Sample weights provided by the DHS data were applied to account for over and undersampling, and adjustments were made for clustering of data using Taylor-linearized variance estimation. Data management and analysis were conducted using Stata version SE 12.

Overall, the study provides insights into the factors associated with antibiotic consumption for children under five in Nepal and highlights the need for interventions to reduce inappropriate antibiotic use while ensuring access to those who need them.

Share this:
Facebook
Twitter
LinkedIn
WhatsApp
Email